Histoblood group antigens, viruses & asthma excerbation
Histoblood group antigens, viruses & asthma excerbation
批准号:
7085384
负责人:
John V Fahy
金额:
$50.7万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-07-01 至 2009-05-31
关键词:
asthmablood group antigensclinical researchcommon colddisease /disorder proneness /riskenzyme activityfucosegenetic susceptibilityglycosidaseshexosyltransferasehuman subjecthuman tissueimmunocytochemistryimmunogeneticsmicroarray technologymucinspatient oriented researchrespiratory epitheliumrespiratory infectionsrhinovirusvirus infection mechanism
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The objective is to explore the role of histoblood group antigens in virus-induced asthma exacerbations. These antigens (ABH and Lewis) decorate O- and N-linked glycans on mucin and epithelial glycoproteins, respectively. Glycan synthesis involves glycosyltransferases, including fucosyltransferases encoded by FUT genes; glycan degradation involves glycosidases, including fucosidase. "Secretor status" is defined by FUT2 activity in epithelial cells, which forms the H antigen and allows subsequent synthesis and secretion of A, B, and Lewis B antigens. In preliminary data, we found that asthmatic subjects with frequent exacerbations are more likely than non-exacerbators to be secretors, that secretors more frequently report that a cold causes asthma, and that sputum in stable asthma has abnormally high fucosidase activity. This suggests that airway glycans are subjected to 2 competing homoeostatic influences, a) the diversity and activity of glycosyltransferases within cells that synthesize glycans, and b) the diversity and activity of glycosidases that turn over and remodel them in the airway lumen. We hypothesize that secretor positive asthmatic subjects are susceptible to virus-induced asthma exacerbation and that abnormal glycosidase activity in secretions modifies the glycan coat and promotes virus-induced exacerbation. In Aim 1, we propose a case control study to compare secretor status in hospitalized asthmatics and outpatient asthmatics without a history of exacerbation. The relationships between secretor status and FUT gene and histo-blood group antigen expression in airway epithelial cells will also be established. In Aims 2 and 3, we will determine if binding of rhinovirus to airway mucins or to airway epithelial cells is influenced by secretor status or by fucosidase activity. In Aim 4 we will determine if Th2 cytokines influence epithelial cell susceptibility to rhinovirus infection by changing epithelial cell expression of glycolytransferases or glycosidases. These are novel lines of inquiry into the mechanisms of virus-induced asthma exacerbation and may prompt novel treatments.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluating the Impact of Metabolic Dysfunction on Asthma Pathology and Physiology
-
批准号:10688260
-
项目类别:
-
资助金额:$77.73万
-
财政年份:2022
-
负责人:John V Fahy
-
依托单位:
Evaluating the Impact of Metabolic Dysfunction on Asthma Pathology and Physiology
-
批准号:10503780
-
项目类别:
-
资助金额:$57.5万
-
财政年份:2022
-
负责人:John V Fahy
-
依托单位:
Sequential, Multiple Assignment, Randomized Trial in Severe Asthma Protocol (SMART-SA)
-
批准号:10454345
-
项目类别:
-
资助金额:$32.89万
-
财政年份:2017
-
负责人:John V Fahy
-
依托单位:
Sequential, Multiple Assignment, Randomized Trial in Severe Asthma Protocol (SMART-SA)
-
批准号:10221035
-
项目类别:
-
资助金额:$37.01万
-
财政年份:2017
-
负责人:John V Fahy
-
依托单位:
Sequential, Multiple Assignment, Randomized Trial in Severe Asthma Protocol (SMART-SA)
-
批准号:9751962
-
项目类别:
-
资助金额:$38.4万
-
财政年份:2017
-
负责人:John V Fahy
-
依托单位:
Carbohydrate-based Therapy for Lung Disease
-
批准号:9766888
-
项目类别:
-
资助金额:$252.7万
-
财政年份:2016
-
负责人:John V Fahy
-
依托单位:
A thiol-saccharide therapy to treat COVID-19
-
批准号:10226074
-
项目类别:
-
资助金额:$76.85万
-
财政年份:2016
-
负责人:John V Fahy
-
依托单位:
Carbohydrate-based Therapy for Lung Disease
-
批准号:10225939
-
项目类别:
-
资助金额:$76.85万
-
财政年份:2016
-
负责人:John V Fahy
-
依托单位:
Carbohydrate-based Therapy for Lung Disease
-
批准号:9147792
-
项目类别:
-
资助金额:$253.43万
-
财政年份:2016
-
负责人:John V Fahy
-
依托单位:
Epithelial cell reprogramming and mucus gel pathology in self-sustaining type 2 airway niches in asthma
-
批准号:10226878
-
项目类别:
-
资助金额:$56.26万
-
财政年份:2012
-
负责人:John V Fahy
-
依托单位:
Exploring the biology of persistent type 2 airway niches in asthma
-
批准号:10472526
-
项目类别:
-
资助金额:$243.9万
-
财政年份:2012
-
负责人:John V Fahy
-
依托单位:
Epithelial cell reprogramming and mucus gel pathology in self-sustaining type 2 airway niches in asthma
-
批准号:10472542
-
项目类别:
-
资助金额:$56.26万
-
财政年份:2012
-
负责人:John V Fahy
-
依托单位:
Core B - Human Subjects Core
-
批准号:10226874
-
项目类别:
-
资助金额:$40.92万
-
财政年份:2012
-
负责人:John V Fahy
-
依托单位:
Core B - Human Subjects Core
-
批准号:10681268
-
项目类别:
-
资助金额:$40.92万
-
财政年份:2012
-
负责人:John V Fahy
-
依托单位:
Exploring the biology of persistent type 2 airway niches in asthma
-
批准号:10006337
-
项目类别:
-
资助金额:$243.9万
-
财政年份:2012
-
负责人:John V Fahy
-
依托单位:
Core B - Human Subjects Core
-
批准号:10472529
-
项目类别:
-
资助金额:$40.92万
-
财政年份:2012
-
负责人:John V Fahy
-
依托单位:
INNATE AND ADAPTIVE IMMUNE RESPONSES IN TH2-HIGH ASTHMA
-
批准号:8339948
-
项目类别:
-
资助金额:$223.11万
-
财政年份:2012
-
负责人:John V Fahy
-
依托单位:
Exploring the biology of persistent type 2 airway niches in asthma
-
批准号:10681265
-
项目类别:
-
资助金额:$243.9万
-
财政年份:2012
-
负责人:John V Fahy
-
依托单位:
INNATE AND ADAPTIVE IMMUNE RESPONSES IN TH2-HIGH ASTHMA
-
批准号:8526521
-
项目类别:
-
资助金额:$212.12万
-
财政年份:2012
-
负责人:John V Fahy
-
依托单位:
Core B - Human Subjects Core
-
批准号:10006349
-
项目类别:
-
资助金额:$40.92万
-
财政年份:2012
-
负责人:John V Fahy
-
依托单位:
海外基金